NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | +50.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | -60.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | 0.0% | 20,000 | -0.6% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | -28.6% | 20,130 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $7,000 | -12.5% | 20,130 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $8,000 | -11.1% | 20,130 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,000 | -10.0% | 20,130 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $10,000 | 0.0% | 20,130 | +0.6% | 0.00% | -20.0% |
| Q1 2017 | $10,000 | +66.7% | 20,000 | +100.0% | 0.01% | +25.0% |
| Q4 2016 | $6,000 | -64.7% | 10,000 | -50.0% | 0.00% | -50.0% |
| Q3 2016 | $17,000 | +70.0% | 20,000 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $10,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sowell Financial Services LLC | 1,507,457 | $593,000 | 0.17% |
| Harel Insurance Investments & Financial Services Ltd. | 780,000 | $398,000 | 0.03% |
| Spark Investment Management LLC | 353,400 | $180,000 | 0.01% |
| LifePlan Financial Group, Inc | 28,810 | $15,000 | 0.01% |
| Greenwich Wealth Management LLC | 60,066 | $31,000 | 0.01% |
| SHINE INVESTMENT ADVISORY SERVICES INC | 19,608 | $10,000 | 0.01% |
| Virtu KCG Holdings LLC | 336,414 | $172,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $9,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $331,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 377,875 | $193,000 | 0.00% |